Clinical Trial Update: Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweating [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the efficacy of Botulinum Toxin B (Myobloc) for prosthesis-associated sweating in hyperhidrosis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis

Drugs mentioned

• MYOBLOC (rimabotulinumtoxinB)

Snippet

Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine | Conditions: Hyperhidrosis | Phase 1 | Status: COMPLETED